Icosavax, Inc.
A biotechnology company in Washington that focuses on developing safe and effective vaccines against infectious diseases.
4
Funding Rounds
$385.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ad** Si***** | - | - | |
| Da*** Ba*** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ad** Si***** | - | - | |
| An* Ve***** | - | - | - |
| Ma** Mc**** | - | - | - |
| Pe*** Ko******** | - | - |
Funding series
Funding Series Analysis
The company Icosavax, Inc. has raised a total of $282m in funding over 4 rounds.
Key Insights:
- Icosavax, Inc. Initial public offering (IPO): $182m
- Icosavax, Inc. funding round, April 2021: $100m
- Icosavax, Inc. funding round, October 2019: $51.01m
- Icosavax funding round, October 2019: $52m
Icosavax, Inc. Initial public offering (IPO)
$182m
Icosavax, Inc. funding round, April 2021
$100m
Icosavax, Inc. funding round, October 2019
$51.01m
Icosavax funding round, October 2019
$52m
Industries
Icosavax, Inc. is active in the following industries:
- Vaccine
- Pharmaceutical industry
- Biomedical engineering
- Engineering
- Technology
- Synthetic biology
- Biology
- Biotechnology
- Healthcare